Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CTMXCTMX
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in CYTOMX THERAPEUTICS INC.

GEODE CAPITAL MANAGEMENT, LLC holds 4.7M shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $17.5M as of 2026-Q2. The position was increased (+126.4% shares). CTMX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$17.5M

Current Shares

4.7M

Total Value Change

+$16.6M

Total Shares Change

+3.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.7M
+126.4%
$17.5M0.0%$3.75
46
2026-Q1
Increased
2.1M
+35.5%
$9.7M0.0%$4.81
36
2025-Q4
Decreased
1.5M
-2.8%
$6.5M0.0%$4.16
0
2025-Q3
Decreased
1.6M
-10.1%
$5M0.0%$3.23
0
2025-Q2
Increased
1.7M
+103.4%
$4M0.0%$2.25
43
2025-Q1
Increased
857,958
+5.2%
$545,6250.0%$0.63
17
2024-Q4
Increased
815,643
+1.5%
$840,3310.0%$1.02
25
2024-Q3
Increased
803,531
+4.4%
$948,3690.0%$1.20
26

Other major holders of CTMX: FMR LLC, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used